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A flavivirus (strain 97-103) was isolated from Culex
pipens mosquitoes in 1997 following floods in South
Moravia, Czech Republic. The strain exhibited close anti-
genic relationship to West Nile virus (WNV) prototype strain
Eg-101 in a cross-neutralization test. In this study, mouse
pathogenicity characteristics and the complete nucleotide
and putative amino acid sequences of isolate 97-103,
named Rabensburg virus (RabV) after a nearby Austrian
city, were determined. RabV shares only 75%–77%
nucleotide identity and 89%–90% amino acid identity with
representative strains of WNV lineages 1 and 2. Another
RabV strain (99-222) was isolated in the same location 2
years later; it showed >99% nucleotide identity to strain 97-
103. Phylogenetic analyses of RabV, WNV strains, and
other members of the Japanese encephalitis virus (JEV)
complex clearly demonstrated that RabV is either a new
(third) lineage of WNV or a novel flavivirus of the JEV
group. 
W
est Nile virus (WNV), a member of the Japanese
encephalitis virus (JEV) group within the genus
Flavivirus, family Flaviviridae, is the most widespread
flavivirus, occurring in Africa, Eurasia, Australia, and
North America. Other members of the JEV group fla-
viviruses are Cacipacore virus (CPCV), Koutango virus
(KOUV), JEV, Murray Valley encephalitis virus (MVEV),
Alfuy virus (ALFV), St. Louis encephalitis virus (SLEV),
Usutu virus (USUV), and Yaounde virus (YAOV) (1).
Although initially WNV was considered to have minor
human health impact, the human and equine outbreaks in
Europe (Romania, Russia, France, Italy), Africa (Algeria,
Tunisia, Morocco), and Asia (Israel) within the last 10
years, and especially the virus’s emergence and spread in
North America since 1999, put it into the focus of scientif-
ic interest. The distribution and ecology of WNV, as well
as clinical features, pathogenesis, and epidemiology of
West Nile disease have been reviewed (2–6). Phylogenetic
analyses showed 2 distinct lineages of WNV strains
(which themselves subdivide into several subclades or
clusters), isolated in different geographic regions (7–10). 
The presence of WNV in central Europe has been
known for some time. Serologic surveys have detected
specific antibodies to WNV in several vertebrate hosts in
Austria, Czech Republic, Hungary, and Slovakia during
the past 40 years, and several virus strains were isolated
from mosquitoes, rodents, and migrating birds (3). Human
cases of West Nile fever were reported in the Czech
Republic in 1997 (11) and in Hungary in 2003 (12).
Although these countries are important transit areas or
final destinations for migratory birds from the African con-
tinent, and hence may play an important role in the circu-
lation and conservation of different WNV strains, genetic
information about the strains isolated in central Europe has
not been available. We report the complete genome
sequence and phylogenetic analyses, as well as antigenic
and mouse virulence characteristics, of a unique flavivirus
strain (97-103), closely related to WNV, which was isolat-
ed by intracranial injection of suckling mice with
homogenates of female Culex pipiens mosquitoes collect-
ed 10 km from Lanzhot, Czech Republic, after a flood in
1997 (11,13,14). The collection site was very close to the
Czech-Austrian border, ≈2 km from the small Austrian
town of Rabensburg. Consequently, the isolate 97-103 was
later tentatively called Rabensburg virus (RabV). Another
antigenically identical or very closely related strain (99-
222) was isolated from Cx. pipiens mosquitoes in the same
location 2 years later (14). 
Methods 
Isolates 97-103 (passage 5 in suckling mouse brain
[SMB]) and 99-222 (passage 4 in SMB) were freeze-dried
in October 2000 (14). Viral RNA was extracted from
140  µL of virus resuspended in diethylpyrocarbonate
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United Arab Emirates.(DEPC)-treated water, using the QIAamp viral RNA Mini
Kit (Qiagen, Hilden, Germany), according to the manufac-
turer’s instructions. For amplification of the complete
genome, oligonucleotide primers were designed with the
help of the Primer Designer 4 for Windows 95 program
(Scientific and Educational Software, version 4.10) and
were synthesized by GibcoBRL Life Technologies, Ltd.
(Paisley, Scotland, UK). A complete list of the 35 primers
used in reverse transcription–polymerase chain reaction
(RT-PCR) and sequencing reactions is available upon
request. Reverse transcription and amplification were per-
formed with a continuous RT-PCR method with the Qiagen
OneStep RT-PCR Kit (Qiagen) following the manufactur-
er’s instructions. Reverse transcription (at 50°C for 30 min)
was followed by a denaturation step at 95°C for 15 min, and
40 cycles of amplification (94°C for 40 s, 57°C for 50 s,
72°C for 1 min). Reactions were completed by a final
extension for 7 min at 72°C, and the amplicons were kept
at 4°C until electrophoresis was carried out. The reactions
were performed in a Perkin-Elmer GeneAmp PCR System
2400 thermocycler (Perkin-Elmer Corp., Wellesley, MA,
USA). After RT-PCR, the amplicons were electrophoresed
in agarose gel, stained with ethidium bromide, and bands
were visualized under UV light. Gels were photographed
with a Kodak DS Electrophoresis Documentation and
Analysis System (Eastman Kodak Company, New Haven,
CT, USA). Product sizes were determined with reference to
a 100 – bp DNA Ladder (Promega, Madison, WI, USA).
Fluorescence-based direct sequencings were performed in
both directions on the PCR products with the ABI Prism
Big Dye Terminator cycle sequencing ready reaction kit
(Perkin-Elmer) and an ABI Prism 310 genetic analyzer
(Perkin-Elmer) automated sequencing system (15).
The nucleotide sequences were identified by BLAST
search against GenBank databases and were compiled and
aligned with the help of the Align Plus 4 for Windows 95
(Scientific and Educational Software, version 4.00) and
ClustalX Multiple Sequence Alignment (version 1.81) pro-
grams. Phylogenetic analysis was performed with the
Phylogeny Inference Program Package (PHYLIP) version
3.57c. Distance matrices were generated by the Fitch pro-
gram, with a translation/transversion ratio of 2.0.
Phylogenetic trees were delineated by using the TreeView
(Win32) program version 1.6.6.
Results
Both virus strains were identified as WNV by comple-
ment fixation and neutralization tests (11,13). Strain 97-
103 was compared antigenically in detail with the
Egyptian Eg-101 topotype strain of WNV (16), a represen-
tative of WNV lineage 1 (clade 1a). In plaque-reduction
cross-neutralization tests (PRNT) with homologous and
heterologous antisera (produced by injection of ICR mice
with 3 intraperitoneal doses at weekly intervals), the serum
raised against Eg-101 neutralized both the homologous
virus and 97-103 at a titer of 512, while the strain 97-103
specific serum was effective against strain Eg-101 only at
a titer of 64, although it neutralized the homologous virus
at 512. The average 4-fold difference in cross-PRNT titers
indicates certain antigenic heterogeneity of the 2 strains,
and the 97-103 isolate was therefore regarded as a subtype
of WNV (14). 
Virulence of RabVstrains 97-103 and 99-222 was deter-
mined by intracranial and intraperitoneal injection of spe-
cific-pathogen-free (SPF) outbred ICR mice. Central
nervous system symptoms (e.g., pareses of hind limbs)
developed in suckling mice, which died 7–15 days after
intracranial injection (Table 1). Adult mice did not show
any clinical symptoms and survived the experimental infec-
tion. On the other hand, the WNV topotype strain Eg-101
caused fatal illness in intracranially injected mice, killing
them within 4 to 6 days after infection, regardless of their
age (11,13). After intraperitoneal injection, strain Eg-101
killed all suckling mice but a <10% of adult mice; RabV
strains 97-103 and 99-222 killed approximately one third of
suckling mice, and the average survival time was 11 days
(range 10–14 days). Thus, both Rabensburg virus strains
exhibit clearly lower virulence for mice than the Egyptian
WNV topotype strain. In addition, average survival time of
suckling ICR mice injected intracranially with RabV was
significantly longer than with strain Eg-101. 
The genome of strain 97-103 Rabensburg virus (RabV)
was investigated by RT-PCR and subsequent direct
sequencing of the amplicons. Initially, oligonucleotide
primers designed on the consensus sequences of linage 1
and 2 WNV strains were applied to the viral nucleic acid
of RabV. On the basis of the sequence information
obtained from these PCR products, specific primer pairs
were designed to produce overlapping amplicons covering
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and the sequences were compiled, resulting in a 10,972 –
nucleotide (nt–) sequence that represented the complete
genome of the virus. The sequence was identified by
BLAST search against GenBank databases. The highest
identity rates of RabV to other flaviviruses (78%–90%)
were found with certain regions of WNV strains of lineage
1 and 2.
From the second isolate (99-222), 5 genomic regions
have been amplified and sequenced so far, showing a total
of 3656 nt. They represent partial coding sections from the
core (C), anchored C, premembrane (PreM), and mem-
brane (M) protein regions (between nucleotide positions
117 and 752); NS3 protein region (between nucleotide
positions 5294 and 5536, and between nucleotide positions
5565 and 6343); NS4b and NS5 regions (between
nucleotide positions 7321 and 8112); and NS5 protein
region (between nucleotide positions 9095 and 10305).
Partial sequence analysis of isolate 99-222 showed >99%
identity to 97-103. Aligned to strain 97-103, only a few
nucleotide substitutions were observed, in the following
positions: C609 to T; C720 to A; G5727 to A (resulting in an
amino acid change Met to Ile); T5910 to C (resulting in an
amino acid change Ile to Thr); T5961 to C; C9630 to A; and
G9843 to T. 
Similar to other flaviviruses (17), the nucleotide
sequence of RabV contains l open reading frame (ORF)
encoding the viral proteins as a large polyprotein precur-
sor. The ORF starts at nucleotide position 97, and codes for
a 3,433-amino acid (aa) polypeptide. The putative amino
acid sequence of the polyprotein precursor gene of RabV
97-103 has been translated; based on the amino acid align-
ment with WNV, the putative mature proteins, conserved
structural elements, and putative enzyme motifs were
localized. The anchored C protein is located between nt 97
and 465; within this region, the C protein is located
between nt 97 and 411. The PreM protein is encoded from
nt 466 to nt 966, with the M protein between nt 742 and
966. The envelope (E) protein is encoded between
nucleotide positions 967 and 2469, followed by the non-
structural proteins NS1 (nt 2470–3525), NS2a (nt
3526–4218), NS2b (nt 4219–4611), NS3 (nt 4612–6468),
NS4a (nt 6469–6846), 2K (nt 6847–6915), NS4b (nt
6916–7680), and NS5 (nt 7681–10395), respectively.
Amino acid identities with WNV were found at the known
conserved positions (i.e., Cys residues involved in
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integrin binding motif of the E protein, catalytic triad and
substrate binding pocket of the trypsin-like serine protease,
RNAhelicase motif of the NS3 protein, and RNA-depend-
ent RNA polymerase motif of the NS5 protein; 15).
To investigate the phylogenetic relationship of RabV to
other WNV isolates, multiple nucleotide and putative
amino acid sequence alignments were made involving 16
WNV strains (listed in Table 2). Although several
complete WNV nucleotide sequences from previously
published studies (10,18) have been deposited in the
GenBank databases, only selected representatives of line-
ages and clades have been included in our alignments, in
order to obtain more precise and demonstrative trees. 
RabV exhibited 73%–77% nucleotide identity rates to
the different WNV strains (Table 3). The relationships
between the strains are demonstrated in Figure 1. The 2
lineages of WNVare obviously separated in the tree. Clade
1a viruses form a tight cluster with close genetic relation-
ship among the members. Kunjin virus, the representative
of clade 1b, appears as a separate branch of lineage 1.
Unfortunately, no complete genome sequence information
is available on clade 1c (Indian strains); thus, they are not
represented in the tree. The prototype Uganda strain B956
(WNFCG) of lineage 2 is grouped together with the
Sarafend strain, a laboratory strain with uncertain origin
and passage history. Two viruses proved to be clearly dis-
tinct with significant genetic distances to all other WNV
strains and also from each other: RabV and strain LEIV-
Krnd88-190 (in the phylogenetic trees designated Rus98).
The latter virus was isolated from Dermacentor margina-
tus ticks in the northwest Caucasus Mountain valley in
1998 and was regarded as a new variant of WNV (19–21).
Because these 2 viruses differ considerably from all WNV
strains, the issue is raised about whether classifying these
2 viruses as separate members of the JEV group might be
more appropriate.
To elucidate this question, a comprehensive phyloge-
netic analysis was performed on all representatives of the
JEV group. Because only partial common sequence infor-
mation of the NS5 protein gene region is currently avail-
able from SLEV, ALV, CPCV, KOUV, and YAOUV (22),
the phylogenetic analysis had to be restricted to this
region (Figure 2). Within the investigated genome stretch,
RabV showed 77%–78% identity to lineage 1 and 2 WNV
strains, 77% identity to strain LEIV-Krnd88-190, and
71%–76% identity to other representatives of the JEV
group. In the phylogenetic tree (Figure 2), the separation
of the 2 unique strains (RabV and LEIV-Krnd88-190 =
Rus98) from WNV is clearly visible. Although RabV
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tives, similar identity rates (76%) exist between MVEV
and USUV, as well as between JEV and ALFV, and these
viruses have been taxonomically classified as separate
viruses. The Rus98 virus clusters together with KOUV, a
virus isolated originally from a Kemp’s gerbil (Tatera
kempi) in Senegal 1968 and subsequently recovered from
other rodent species and several genera of ticks
(Rhipicephalus, Hyalomma, Alectorobius) in central
Africa (23). The Rus98 strain was also isolated from
ticks. 
The putative amino acid sequence of RabV was also
compared with the corresponding sequences of representa-
tives of WNV lineages and clades, as well as with other
JEV group viruses on the available polypeptide sequence
regions. RabV shared 89%–90% identity on the complete
polypeptide precursor region with the WNV strains, 87%
identity with the Rus89 strain, and 75%–76% identity with
JEV, USUV, and MVEV. The alignments of the partial
amino acid sequences of the NS5 region (between aa 2991
and 3335) showed 94%–96% identity rates with the WNV
strains, 95% with strain Rus98, and 78%–90% with the
other members of the JEV group (Table 3). Phylogenetic
trees, based on the amino acid alignments, displayed near-
ly identical topology to nucleotide sequence–based trees
(data not shown). The complete genome sequence of RabV
(flavivirus strain 97-103) has been deposited in GenBank
under accession no. AY765264. 
Discussion
WNV strains of different lineages exhibit considerable
genomic diversity (76%–77% nucleotide identity only). At
the same time, WNV is not sharply delimited genomically
from the other members of the JEV group. The available
partial sequences of the NS5 gene region from other virus-
es of the group show 71%–76% nucleotide and 78%–90%
amino acid identities to WNV strains. The closest relatives
of WNV are KOUV and YAOV (10,22–24). 
Lineage 1 of WNV comprises strains from several con-
tinents and is subdivided into at least 3 clades. In clade 1a,
several subclades or clusters are formed by closely related
strains, such as strains isolated 40–50 years ago in Europe
and Africa; strains isolated 20–30 years ago in Africa;
strains isolated within the last 10 years in Europe and
Africa; and strains isolated within the last 5 years in the
United States and Israel. Clade 1b consists of the
Australian isolates (Kunjin), while clade 1c contains
strains from India. Lineage 2 is composed of WNV strains
that have been isolated, so far exclusively, in the sub-
Saharan region of Africa and in Madagascar (18). The
genetic distance between the 2 lineages is relatively great
in contrast to that within some representatives of lineage 1
that were isolated in distant geographic locations and with-
in considerable time intervals. While the viruses in clade
1a share 95.2%–99.9% nucleotide and 99.3%–100%
amino acid identity to each other, and also 86.6%–87.8%
nucleotide and 97.4%–97.7% amino acid identity to the
clade 1b viruses, the overall identity rates between lineage
1 and 2 are only 75.7%–76.8% on nucleotide level and
93.2%–94.0% on amino acid level (18), identity rates that
resemble those between RabV and either lineage 1 or line-
age 2 WNV strains. Besides genomic differences, anti-
genic variability can be observed in cross-neutralization
analyses and monoclonal antibody binding assays (8,18).
The results of the phylogenetic analyses indicate that
viruses closely related to WNV are present in central
Europe and southern Russia. Although these viruses have
initially been identified as WNV, they can be regarded, on
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Figure 1. Phylogenetic tree illustrating the genetic relationship
between selected West Nile virus strains based on their complete
genome sequences. Bar on the left demonstrates the genetic dis-
tance. (Abbreviations and accession numbers are listed in Table 2.) the basis of their genetic distances, either as separate line-
ages of WNV (RabV: lineage 3; LEIV-Krnd88-190 =
Rus98: lineage 4) or as new viruses within the JEV group.
The antigenic and biologic differences between RabV and
the WNV reference strain Eg-101 also support this opin-
ion. Isolation of RabV in 1997 was obviously not an iso-
lated event; rather, flaviviruses of the RabV type seem to
be present or persist in this area, as demonstrated by the
isolation of an almost identical virus strain (99-222) 2
years later (14). The ecology of RabV needs further inves-
tigation. Other unanswered questions concern the patho-
genicity and host spectrum of the virus, especially
regarding possible human infections. 
To summarize, a novel flavivirus strain of unknown
human pathogenicity, repeatedly isolated from Cx. pipiens
mosquitoes in central Europe, has been molecularly char-
acterized, including determination of its complete
nucleotide and deduced amino acid sequences. Based on
the analysis of the virus and comparison with related virus-
es including phylogenetic relationships, we suggest that
RabV be classified either as a new (third) lineage of WNV
or as a novel flavivirus within the JEV group. 
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